Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

57.35
+0.59001.04%
Post-market: 42.79-14.5600-25.39%19:59 EDT
Volume:1.83M
Turnover:98.86M
Market Cap:5.54B
PE:-12.19
High:58.15
Open:57.60
Low:56.87
Close:56.76
52wk High:72.66
52wk Low:35.97
Shares:96.64M
Float Shares:95.45M
Volume Ratio:3.07
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:4.46
PE(LYR):-13.14

Loading ...

Evercore ISI Reaffirms Their Buy Rating on Xenon (XENE)

TIPRANKS
·
Aug 08

Wedbush Adjusts PTon Xenon Pharmaceuticals to $71 From $63, Maintains Outperform Rating

MT Newswires Live
·
Aug 07

RBC Adjusts Xenon Pharmaceuticals PT to $81 From $82, Maintains Outperform Speculative Risk Rating

MT Newswires Live
·
Aug 07

Xenon Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 07

Earnings Flash (XENE) Xenon Posts Q2 Loss Per Share $1.11, vs. FactSet Est of $1.14 Loss

MT Newswires Live
·
Aug 07

Xenon Pharmaceuticals reports Q2 EPS ($1.11), consensus ($1.16)

TIPRANKS
·
Aug 07

Canada's Xenon Pharma Q2 Net Loss Widens on Higher Expenses

Reuters
·
Aug 07

Xenon Net Loss Widens 30.7% to $110.74 Million in Q2 FY26

Reuters
·
Aug 07

Xenon Pharmaceuticals Q2 EPS $(1.11) Beats $(1.15) Estimate

Benzinga Earnings
·
Aug 07

Xenon Pharmaceuticals Q2 Net Income USD -110.736 Million Vs. IBES Estimate USD -105.7 Million

Reuters
·
Aug 07

Xenon Pharmaceuticals Q2 Operating Expenses USD 123.155 Million

THOMSON REUTERS
·
Aug 07

Xenon Pharmaceuticals - Anticipates Sufficient Cash to Fund Operations into 2029

THOMSON REUTERS
·
Aug 07

Xenon Reports Q2 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 07

Xenon Pharma Grants 32,758 Inducement Stock Options, 19,013 RSUs to New Hires

Reuters
·
Aug 01

Xenon Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 01

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 01

Movement Alert|Xenon Pharmaceuticals Falls 5.07% in Regular Trading, Trading at $67.3

Market Focus
·
Jul 10

Movement Alert|Xenon Pharmaceuticals Rises 7.25% in Regular Trading, Trading at $68.07

Market Focus
·
Jul 09

Xenon Pharmaceuticals Grants 20,200 Inducement Stock Options, 11,850 Rsus to New Hires

Reuters
·
Jul 03

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 03